HIV Drug Nelfinavir Shows Promise in Fighting HER-2 Positive Breast Cancer

HIV Drug Nelfinavir Shows Promise in Fighting HER-2 Positive Breast CancerFIRST PERSON | A recent study published in the Journal of the National Cancer Institute shows that the HIV drug Nelfinavir exhibits promise in fighting HER-2 breast cancer. This is an important study as HER-2 breast cancer is extremely aggressive and difficult to control. HER-2 breast cancers have a higher rate of recurrence than other types of breast cancer.



Sexual Health News Headlines – Yahoo! News